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ABSTRACT
Using cell lines and primary cells, it has been shown that translation control plays a key role regulating gene expression during
physiological and pathological conditions. The relevance of this type of regulation in vivo (tissues, organs) remains to be
elucidated, due to the lack of an efficient method for polysome-bound fractionation of solid tissue RNA samples. A simple and
efficient method is described, in which tissue samples were pulverized in liquid nitrogen and lysed with NP40-lysis buffer in the
presence of the RNAse inhibitors RNAsin and vanadyl-ribonucleoside complex. After cell lysis, the cytoplasmic extract was
loaded into sucrose gradients, fractionated, and RNA prepared from each fraction. The obtained RNA was reverse transcribed
with a low efficiency, a problem that was overcome by purifying polyA+ RNA. Aiming to use small quantities of solid tissue
samples (10–20 mg/sample), polyA+ RNA purification was discarded, and the different components were individually screened
for a negative effect on reverse transcription. The polysaccharide heparin, which is present as a nonspecific RNAse inhibitor,
inhibits reverse transcriptase activity, and must be removed from RNA samples for an efficient reaction. Heparin was
successfully removed by precipitation of the RNA with lithium chloride, as demonstrated by the reversal of the inhibition on
RT-PCR reactions. In summary, we present a reliable method allowing us to prepare high-quality polysome-bound mRNA from
small quantities of liquid-nitrogen–frozen solid tissue samples from both human and mouse origin, amenable for Northern
blotting, RT-PCR reactions, and expression profiling analyses.
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INTRODUCTION
Redistribution of mRNA between ribosome-free and
polysome-bound fractions has been used to ascertain
translational control of a given mRNA by Northern hybrid-
ization (Leibold and Munro 1988; Garcia-Sanz and Lenig
1996), and more recently in expression profiling analysis
(Johannes et al. 1999; Zong et al. 1999; Mikulits et al. 2000).
This can be done since translational control takes place,
mainly at the initiation step (Mathews et al. 2000), and
thus ribosome loading of a transcript is a robust indicator
for translation efficiency. Indeed, genome-wide analyses
of translationally regulated transcripts showed that 15%–
40% of the regulated transcripts during physiological/
pathological transitions are regulated at the translational
level, indicating that translational control is a generalized
mechanism of gene expression regulation (Pradet-Balade
et al. 2001a). Examples of the major role of translational
control stem from studies on T cell activation (Mikulits
et al. 2000), epithelial-mesenchymal transition (Jechlinger
et al. 2003), terminal erythroid differentiation (Blazquez-
Domingo et al. 2005), and also from drug treatment
(Grolleau et al. 2002), PDK1 signaling (Tominaga et al.
2005), or the early effects of the transcription factor Ras, in
combination with AKT, which involves the differential
recruitment of specific mRNAs to polysomes (Rajasekhar
et al. 2003).
These data, which indicate the prominent role of trans-
lational control regulating gene expression, together with
the lack of correlation between protein levels and levels of
the corresponding mRNAs in expression profiling analyses
(Tew et al. 1996; Gygi et al. 1999a,b), led us to propose that
polysome-bound mRNA profiling more faithfully would
represent cell phenotypes than the common profiling using
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total RNA, since polysome-bound profiling would allow
us to identify, in addition to changes in transcription or
mRNA stability (also detected by total mRNA expression
profiling), changes in splicing efficiency, nucleo-cytoplas-
mic transport, and translation efficiency (Pradet-Balade
et al. 2001a). This hypothesis, initially strengthened by the
demonstration that polysome-bound profiling can detect
changes observed in the proteome but undetectable by total
RNA expression profiling (Grolleau et al. 2002), was sub-
sequently confirmed by a large set of publications in which
polysome-bound mRNA profiling allowed identifying
translationally regulated genes. Indeed, this has been
demonstrated in model systems as diverse as the response
to Ras and AKT signaling (Rajasekhar et al. 2003), dehy-
dration of Arabidopsis (Kawaguchi et al. 2004), hypoxia
(Wouters et al. 2005), mating pheromone in yeast (MacKay
et al. 2004), regulation of retinoic acid receptor in poly-
morphonuclear cells (Yost et al. 2004), inflammatory
signals in neutrophils (Lindemann et al. 2004), analysis of
breast cancer cell lines (Huber et al. 2004), osteosarcoma
(Ju et al. 2003), erythroid differentiation (Joosten et al.
2004), or epithelial mesenchymal transition (Jung et al.
1997), which by now are represented by >50 publications.
Initially, the identification of translationally regulated
genes was done by determining changes in the ratio
between ribosome-free/polysome-bound signals for each
gene (Johannes et al. 1999; Zong et al. 1999; Mikulits et al.
2000). The actual demonstration that the sum of signals
from ribosome-free and polysome-bound fractions equals
the signal from the total RNA for a the vast majority of
genes (Pradet-Balade et al. 2001b) allowed us to ascertain
that changes in translation efficiency correspond to changes
in the ratio polysome-bound/total RNA, and thus to
distinguish between changes in transcription/mRNA sta-
bility versus changes in translation control, splicing, or
nucleo-cytoplasmic export.
Thus, once the relevance of translational control was
established in tissue-cultured cells and primary cells, it
became highly interesting to establish a methodology that
would also allow reliable preparations of ribosome-free and
polysome-bound mRNA from small solid tissue samples,
amenable for RT-PCR, Northern blotting, and expression
profiling. Here we describe such a protocol for isolation of
polysome-bound mRNA from solid tissues that has been
applied to different mouse and human samples (kidney,
brain, mammary gland) to obtain high-quality RNA,
suitable for polysome-bound profiling experiments. Fur-
thermore, we tested the effects of the RNAse inhibitor
vanadyl-ribonucleoside complex (VRC) on the quality of
the data and describe an efficient method to avoid the
inhibition of the reverse transcriptase due to the heparin
used in polysome gradient fractionations as an unspecific
RNAse inhibitor that allows us to directly use total RNA
(instead of polyA+ RNA) in polysome-bound expression
profiling experiments.
RESULTS
Discrimination between actively translated and translation-
ally silent mRNAs in the cell can be efficiently carried out
using sucrose-gradient fractionation (polysome gradients),
since this technique allows separation of free ribonucleo-
protein particles (ribosome-free mRNA) from mRNAs
bound to an increasing number of ribosomes (polysome-
bound mRNA). Fractionation of cytoplasmic cell extracts
in sucrose gradients has been restricted, for technical
reasons, to cultured cell lines and primary lymphoid cells.
Wishing to extend this type of analysis to solid tissues, we
have modified the methodology used so far to allow an
efficient preparation, after sucrose-gradient fractionation,
of high-quality RNA using relatively small tissue samples
(in the range of 10–20 mg), amenable for Northern blot,
RT-PCR, and expression profiling analyses.
Polysome gradient fractionation from solid tissues
A series of changes had to be made to the method currently
used to prepare sucrose gradients from cell lines to make it
amenable for solid tissue samples, namely: (1) quick freez-
ing of the sample in liquid nitrogen; (2) pulverization of
the sample under liquid nitrogen; and (3) addition of VRC
to the lysis buffer as a strong RNAse inhibitor, as RNAsin
alone was not sufficiently effective in blocking RNAse
activity in the samples. Since it was considered that this
type of analysis might also be used for relatively small
samples (i.e., biopsies), small amounts of tissue (in the
range of 10–20 mg) were used.
Tissue samples of interest were transferred to siliconized
microcentrifuge tubes and immediately frozen under liquid
nitrogen. These samples were stored under liquid nitrogen
or at 80°C until processing. The RNA extraction pro-
cedure begins with pulverization of the tissue under liquid
nitrogen for which a mortar and a pestle, both RNAse free
and previously cooled with liquid nitrogen, are used. The
powder obtained is transferred to a microcentrifuge tube
maintained for at least 5 min on dry ice, to minimize RNA
degradation by avoiding thawing of the pulverized tissue.
Afterward, the tissue powder is resuspended in lysis buffer
(NP40 based) and the cells disrupted as quickly as possible
by pipetting up and down 10 times, maintaining a ratio of
tissue sample to buffer of 1 mL lysis buffer/10 mg tissue
(Fig. 1). After lysis, intact nuclei are pelleted at 4°C, for
10 sec at 12,000g in a microcentrifuge. The supernatant
containing the cytoplasmic extract is transferred to a fresh
microcentrifuge tube containing 23 extraction buffer (see
Materials and Methods), under conditions where ribo-
somes bound to mRNAs remain ‘‘frozen’’ there by the
presence of cycloheximide. Cellular debris, including mito-
chondria, are removed by subsequent centrifugation at
12,000g for 5 min, and the supernatant is loaded onto a
15%–40% sucrose gradient (Mu¨llner and Garcia-Sanz
Isolation of polysome-bound RNA from solid tissues
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1997b). During centrifugation, mRNAs distribute into the
different fractions of the gradient, based on their ribosome
load (Fig. 1; Mu¨llner and Garcia-Sanz 1997b).
This protocol was used to prepare polysome gradients
from mouse mammary gland. Bioanalyzer profiles from
these fractions demonstrate the quality of the fractionation
as well as the RNA quality from each fraction (Fig. 2A).
Subsequently, the RNA from each fraction was precipitated
with 2 M LiCl, to remove contaminating heparin that
would inhibit the reverse transcriptase (see Materials and
Methods). The distribution in the gradient of several genes,
including p53, p21, mdm2, and BAX, as well as of the
eukaryotic translation initiation factor 1 a (eIF1a), was
analyzed by quantitative RT-PCR on each fraction from
the gradient. The data from Figure 2C show that a large
FIGURE 1. Schematic representation of the protocol allowing iso-
lation of polysome-bound mRNAs from small solid tissue samples.
Dissected tissue samples (10–20 mg) are quickly frozen under liquid
nitrogen (A). Frozen samples are crushed to powder in a mortar
under liquid nitrogen (B). The powder is transferred to a micro-
centrifuge tube and lysed with NP40-lysis buffer in the presence
of VRC (C). After nuclei removal, ribosomes are immobilized on
mRNAs with cycloheximide (present in the 23 extraction buffer)
(D); the cytoplasmic extract is loaded onto a 15%–40% sucrose
gradient (E), spun for 2 h, and 20 fractions harvested. Each fraction
is deproteinized and the RNA recovered after phenol-choloroform-
isoamylalcohol extraction and subsequent ethanol precipitation
(F). After fractionation, RNA fractionated on a sucrose gradient
migrated on a Northern blot as shown. The top fractions are
characterized by the presence of the tRNAs; next, fractions corre-
sponding to a peak migration of the small 40S ribosomal subunit
(revealed by the peak of 18S rRNA), followed by the peak migration
of the large 60S ribosomal subunit (peak of 28S rRNA) contain
tRNA. Fractions below contain mRNAs with one or more ribosomes
attached to them.
FIGURE 2. Sucrose gradients from mammary tissue samples.
Sucrose-gradient fractionation from mouse mammary gland tissue
was carried out from samples of X-ray irradiated adult female mice.
The processing of the samples was carried out as described in Figure 1.
The quality of the sucrose fractionation and of the RNA in each
fraction was determined with a Bioanalyzer (Agilent) (A), as well as in
a control gradient in which the tissue was lysed in the presence of
25 mM EDTA (B) (EDTA release control), in which the presence of
EDTA leads to the shift of mRNAs from the polysome-bound fraction
toward lighter sucrose fractions (monosomes). The arrowhead indi-
cates the peak corresponding to a marker RNA added to each sample,
and the peaks corresponding to tRNA, 18S, and 28S RNAs are
indicated. The RNA on each fraction was reverse transcribed and
aliquots amplified with specific primers and the corresponding probes
(UniversalProbe Library probes, Roche) by qPCR. For the amplifica-
tion, genes implicated in DNA-damage responses (p53, p21, BAX,
Mdm2) and eIF1a (see Materials and Methods for details) were used.
The data are presented as percentage of the total amount of RNA on
each fraction (C). (Empty circles) fractions of a polysome gradient
prepared in the absence of EDTA; (filled circles) fractions of a
polysome gradient prepared in the presence of EDTA.
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fraction of the transcripts coding for the
genotoxic-response genes p53, p21, and
mdm2, and also the transcripts coding
for eIF1a mRNA, are in the heavy
sucrose fractions, most likely bound
to a large amount of ribosomes (poly-
somes) (Fig. 2C).
To ascertain that indeed p53, p21,
mdm2, and eIF1a transcripts were
bound to polysomes, the lysis of the
cells was carried out in the presence of
the Ca++/Mg++ chelating agent EDTA
(EDTA-release experiment), which leads
to the redistribution of polysome-
bound mRNAs toward fractions of
lower density (monosomes), as previ-
ously described (Pastori and Schoenberg
1993; Beck and De Maio 1994; Ohashi
et al. 2002). Indeed, the EDTA-release
experiment demonstrates a redistribu-
tion of p53, p21, mdm2, and eIF1a
mRNAs toward less-dense fractions
(monosomes) (Fig. 2C), indicating that
these transcripts are efficiently translated
in the mouse mammary gland several
hours after X-ray irradiation (Fig. 2C).
The same protocol was successfully used
for sucrose-gradient fractionation of other
mouse and human tissues (Fig. 3), where
samples were analyzed by methylene blue
staining of the corresponding Northern
blots. Hybridization of the blots with a
b-actin-specific cDNA probe revealed a
distribution of the b-actin mRNA charac-
teristic of each tissue (Fig. 3B).
Heparin inhibition of reverse transcriptase is fully
reverted by lithium chloride
Initially we observed very low reverse-transcription yields
from sucrose-fractionated RNA samples, as reflected by
inefficient PCR amplifications and cRNA synthesis, imply-
ing that for profiling analysis to become feasible polyA+
RNA had to be used, requiring larger samples to quanti-
tatively prepare polyA+ RNA. Since one of the aims of this
work was to enable the use small samples (i.e., from
biopsies), we analyzed the reasons for the inefficient reverse
transcription reaction. Two lines of argument indicated
that this was not due to the quality of the RNA obtained.
First, polyA+ mRNA purified from these samples could be
reverse transcribed with high efficiency. Second, analysis of
polysome gradients gave an inhibition in the amplification
not only of the mRNAs analyzed, but also cRNA amplified
with the same primers in competitive RT-PCR reactions
(J.A. Garcia-Sanz, unpubl.).
A literature search for inhibitors of the reverse transcrip-
tase allowed identification of heparin as a possible inhibitor
in the sucrose-gradient samples. Indeed, heparin, com-
monly used in sucrose-gradient fractionation (650 mg/mL)
as an unspecific RNAse inhibitor (Ukita et al. 1962), in
concentrations of 5 mg/mL inhibits 50% of the Superscript
II reverse transcriptase activity (Gerard 1994). Thus, if
only 1/100 of the original heparin concentration remained
through the phenol-chloroform extraction and ethanol
precipitation steps, reverse transcriptase activity should be
at least partially inhibited.
It has been shown previously for RNA samples from
heparinized clinical specimens that precipitation with 2 M
lithium chloride (LiCl) is able to remove heparin (Jung
et al. 1997). Thus, we tested if a similar treatment of
polysome gradient samples would remove the inhibitory
effect. For this purpose, RNA from a pool of polysome
gradient fractions from Jurkat cells was divided in two
FIGURE 3. Sucrose gradients from solid tissue samples. Sucrose-gradient fractionation of
mRNAs from mouse brain and kidney as well as from human breast samples were carried out
as described in Figure 1. Staining of the corresponding filters with methylene blue shows the
fractionation of cellular RNA, according to its ribosomal load. The integrity of the mRNA was
assessed after Northern hybridization with a b-actin cDNA probe (A). The hybridization
signals of b-actin mRNA were quantified using a PhosphorImager, and the distribution of this
mRNA in the sucrose gradients is depicted as percentage of the mRNA in each fraction (B).
Isolation of polysome-bound RNA from solid tissues
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parts: RNA from one half was precipitated with LiCl
(see Materials and Methods), whereas the other half was
ethanol precipitated (control) (Fig. 3A). Afterward an aliquot
from each sample was used for quantitative RT-PCR using
b-actin specific cDNA primers. Quantification of the results
demonstrated an improvement (z500-fold increase) in the
amplified cDNA signal from the sample precipitated with LiCl
(Fig. 3A).
To prove that indeed heparin had been removed by the
LiCl precipitation, cytoplasmic RNA extracted from
Jurkat cells prepared in the absence of heparin was spiked
with an amount of heparin (650 mg/mL) equivalent to the
concentration in polysome gradients. Thereafter, again,
one aliquot of the RNA was precipitated with LiCl,
whereas the other was precipitated with ethanol. Both
RNA samples were analyzed using the same quantitative
RT-PCR reaction as above. As additional controls, ali-
quots of Jurkat RNA without heparin were precipitated
either with LiCl or ethanol. The results obtained demon-
strate that, as expected, heparin at the concentration used
fully inhibited amplification of b-actin mRNA. Notably,
the LiCl precipitation was able to fully revert the inhibi-
tion of the reverse transcriptase activity since the ampli-
fication curve was similar to the one obtained in the
aliquots devoid of heparin (Fig. 3B). LiCl precipitation
itself did not have a noticeable effect on the amplification
(Fig. 3B). Furthermore, comparison of the amplification
profiles of similar amounts of cytoplasmic RNA (Fig. 3B)
and polysome-fractionated RNA after LiCl precipitation
(Fig. 3A) indicate that heparin is the major inhibitor of
the reverse transcriptase present in the sucrose-gradient
fractions.
The potent RNAse inhibitor VRC used for the sucrose
fractionation (Gray 1974; Egberts et al. 1977; Berger and
Birkenmeier 1979) does not affect reverse-transcriptase
activity when used at 10 mM concentrations on polysome
gradients (data not shown).
DISCUSSION
The method outlined above was designed to meet the need
for the preparation of polysome-bound mRNA from small
samples obtained from solid tissues, which will allow
determining the role of translational control during phys-
iological or pathological changes in these tissues or organs,
even from biopsy samples. By using this protocol, sucrose-
gradient fractionated RNA from three different tissues, two
of mouse and one of human origin, were successfully
prepared. The RNA obtained from these samples derived
from brain, kidney, and mammary gland, was amenable to
Northern blotting, RT-PCR, and expression profiling anal-
ysis (data not shown). One critical point of the method is
that optimally small samples (10–20 mg each) must be
quickly frozen under liquid nitrogen and then can be stored
at 80°C for prolonged periods, which may be of interest
for the use of human biopsy material. For processing of the
samples, the first step is pulverization of tissue with a
mortar and pestle. This step requires maintaining the tissue
frozen: the mortar is filled with liquid nitrogen with the
pestle inside. Once cold, the tissue is added and then
pulverized until a fine powder is obtained, adding more
liquid nitrogen when necessary. The powder is then trans-
ferred to a microcentrifuge tube precooled in dry ice, and
NP40 lysis buffer containing RNAsin and VRC are added.
Importantly, in our hands and with the tissue samples
tested (in contrast to cell line derived material), RNAsin
alone was clearly insufficient to prevent severe RNA degra-
dation. Only the combination of RNAsin and VRC worked
effectively. After lysis and removal of the nuclei and tissue
debris, an equal volume of 23 extraction buffer, supple-
mented with cycloheximide, PMSF, and heparin, was added
to the sample, which was subsequently centrifuged to
remove mitochondria and membranous debris and then
layered onto the 15%–40% sucrose gradients. It should be
noted that with the equipment described the protocol
cannot be scaled up further since there is a limitation
in the volume of cytoplasmic extract (1–2 mL, correspond-
ing to 10–20 mg of tissue) to be layered onto the gradient
(10 mL).
Our data also show that purification of the initial RNA
to obtain polyA+ RNA for reverse transcription/cRNA
synthesis is not required. We can avoid problems with
quantitative mRNA preparation for small samples if hep-
arin is removed after preparation of the RNA by a LiCl
precipitation step. This step is critical since the residual
amount of heparin in the samples, even after phenol-
choloroform-isoamylalcohol extraction and ethanol pre-
cipitation, inhibits reverse transcriptase activity z500-fold
(Fig. 4A). LiCl precipitation is able to fully remove 650 mg/mL
heparin, as demonstrated by the improved efficiency of
RT-PCR amplification (see Fig. 4B). On the other hand,
VCR, either alone or in combination with heparin, had any
effect on reverse transcription after the usual purification
steps (data not shown).
In conclusion, we describe a protocol that allows the
efficient preparation of ribosome-free and polysome-
bound mRNAs from solid tissue samples. Furthermore,
the lithium chloride precipitation of the RNA allows us to
start from samples of smaller size, since this precipi-
tation step efficiently depletes the samples of the reverse-
transcriptase inhibitor heparin, and makes it unnecessary to
quantitatively purify polyA+ RNA. We believe that this
represents a significant improvement since, with the use of
this protocol, it makes the fractionation of the RNA from
solid tissues into ribosome-free and polysome-bound frac-
tions amenable for analysis of biopsy samples by Northern
blotting, RT-PCR, and expression profiling experiments,
in which only the actively translated mRNAs from the cell
are taken into account.
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MATERIALS AND METHODS
Tissue samples
C57Bl/6 and BALB/c female mice, 6–12 wk old, were used to
obtain tissue samples for the experiments described below.
Euthanasia was carried out in a CO2 chamber for 5 min; mam-
mary glands were obtained from a C56Bl/6 female, 16 h after
whole body X-ray irradiation (20 Gy). Animals were housed and
bred in our animal facility and in all experiments treated in
accordance with the European Union and National Guide Lines
and the Helsinki Declaration. Human primary breast cancer tissue
samples were obtained through Drs. Carmen Rodriguez and
Charles Theillet from the mammary tissue bank at the Pathology
Department of the Val d’Aurelle Cancer Center (Montpellier,
France).
Preparation of cytoplasmic RNA
Cytoplasmic RNA from Jurkat cells, a human leukemia cell line
(ATCC #TIB152) (Schneider et al. 1977), was obtained following
lysis of cells in NP40-lysis buffer (10 mM Tris-HCl at pH 8.0,
140 mM NaCl, 1.5 mM MgCl2, 0.5% Nonidet-P40, 20 mM
dithiothreitol, 500 U/mL RNAsin [Blackburn et al. 1977], and
0.5% [w/v] deoxycholate), nuclei were pelleted at 12,000g for
10 sec, and the cytoplasmic extract digested with 10 mg/mL
Proteinase K in the presence of 1% sodium dodecyl sulfate
(SDS) and 10 mM EDTA (pH 8.0) for 30 min at 37°C as
described (Mu¨llner and Garcia-Sanz 1997c), after a modification
from Favaloro et al. (1980).
Polysome gradient preparation
A piece of z20 mg solid tissue was pulverized under liquid
nitrogen and the powder lysed in 1 mL of lysis buffer (10 mM
Tris-HCl at pH 8.0, 150 mM NaCl, 5 mM MgCl2, 1% Nonidet-
P40, 40 mM dithiothreitol, 500 U/mL RNAsin [Promega], 40 mM
VRC [Berger and Birkenmeier 1979] [New England Bio Labs])
supplemented with 1% deoxycholate (Fluka). After lysing the cells
by pipetting up and down several times, the nuclei were removed
by centrifugation (12,000g, 10 sec, at 4°C), and the supernatant
was supplemented with 500 mL of 23 extraction buffer (0.2 M
Tris-HCl at pH 7.5, 0.3 M NaCl), 150 mg/mL cycloheximide,
650 mg/mL heparin, and 10 mM phenyl-methyl-sulfonyl fluoride,
and centrifuged (12,000g, 5 min, at 4°C) to remove mitochondria
and membranous debris. The supernatant was layered onto a
10 mL linear sucrose gradient (15%–40% sucrose [w/v], supple-
mented with 10 mM Tris-HCl at pH 7.5, 140 mM NaCl, 1.5 mM
MgCl2, 10 mM dithiothreitol, 100 mg/mL cycloheximide, 0.5 mg/
mL heparin) (Mu¨llner and Garcia-Sanz 1997b) and centrifuged in
a SW41Ti rotor (Beckman) for 120 min at 38,000 rpm at 4°C,
with brake off. Fractions (20 mL 3 550 mL) were collected and
digested with 100 mg proteinase K in 1% SDS and 10 mM EDTA
for 30 min at 37°C. RNAs were recovered by extraction with an
equal volume of phenol-chloroform-isoamyl alcohol, followed by
ethanol precipitation. As a control, an EDTA release experiment
was made as described before, where the lysis buffer was
supplemented with 25 mM EDTA (pH 8.0).
Northern blotting
After electrophoresis of RNA from the polysome gradients
through denaturing 1.2% formaldehyde-agarose gels, RNA sam-
ples were transferred to nylon membranes (GeneScreen, NEN)
and rRNA distribution visualized by methylene blue staining
(Mu¨llner and Garcia-Sanz 1997a). Northern blots were hybridized
with a b-actin cDNA probe (the 1.1-kb PstI–PstI fragment of
mouse b-actin cDNA, which hybridizes with both mouse and
human samples) labeled with [a-32P]dCTP, using the random
priming method. After washes, filters were exposed and quantified
by a PhosphorImager (Molecular Dynamics). The background
from each sample was subtracted using the local median algo-
rithm of the ImageQuant program (version 1.2, Molecular
Dynamics).
LiCl precipitation of RNA
Cytoplasmic RNA or pools of fractions containing polysome-
bound mRNA, before being reverse transcribed, when indicated,
were precipitated with 2 M LiCl on ice at 4°C overnight (Jung
et al. 1997). After centrifugation (12,000g, 15 min at 4°C), pellets
were washed twice with 70% ETOH (prestored at 20°C), air-
dried, and resuspended in appropriate volumes of RNAse-free
FIGURE 4. Lithium chloride precipitation of the samples abrogates
heparin inhibition of the reverse transcriptase. Quantitative RT-
PCR amplification of b-actin mRNA from polysome-bound RNA
(prepared with heparin), precipitated with either lithium chloride
(+LiCl) or ethanol (LiCl) (A). Aliquots of cytoplasmic Jurkat RNA
(prepared in the absence of heparin) were mixed with heparin
(650 mg/mL) and subsequently divided in two, one precipitated with
lithium chloride (+heparin, +LiCl), or precipitated with ethanol
(+heparin, LiCl). Samples devoid of heparin and precipitated with
either LiCl (heparin, +LiCl) or with ethanol (heparin, LiCl) were
used as controls. The quantitative amplification of the b-actin
mRNA is illustrated for the different conditions (B).
Isolation of polysome-bound RNA from solid tissues
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water. For control purposes (LiCl), RNAs were precipitated with
0.3 M NaAc, 2.5 vol. 100% ETOH, and 1 mL glycogen (20 mg/mL,
Roche). After centrifugation (12,000g, 15 min at 4°C), these
pellets also were resuspended in RNAse-free water.
Quantitative PCR
RNA (5 mg) was reverse-transcribed using random hexamers and
100 U Superscript II RT (Invitrogen). Real-time PCR was
performed on an ABI Prism 7700 (Applied Biosystems), using
SYBR Green PCR Core Reagents (Applied Biosystems). The final
MgCl2 concentration was 1.5 mM, and primers were used at
0.4 mM. Reactions were incubated 2 min at 50°C, 10 min at 95°C,
followed by 40 cycles of 15 sec at 95°C, and 90 sec at 67°C. Specific
primers were designed with PrimerExpress software (Applied
Biosystems); amplified sequences spanned different exons. Differ-
ences in cDNA load were corrected for the amount of amplified
28S rRNA. mRNA expression levels are shown as DRn signal in
each cycle.
RT-qPCR from each fraction from a polysome gradient was
done using the Transcriptor First Strand cDNA Synthesis Kit
(Roche), by random hexamers priming at 50°C for 1 h, following
the manufacturer’s instructions. Since the RNA amount on each
fraction was different, in order to avoid efficiency differences of
the reverse transcriptase, the RNA amounts were equalized by
adding an appropriate amount of luciferase RNA to each fraction
(negative control), giving a final amount of 1 mg of RNA on each
sample. After synthesis of the cDNA first strand, qPCR was
performed on an ABI Prism 7900 (Applied Biosystems), using
the FastStart Taqman Probe Master (Rox) (Roche) and with sets
of primers and Universal ProbeLibrary probes (Roche) designed
online with ProbeFinder version 2.20 (Roche). Probes specific
for eIF1a (forward primer: 59-CGCTGCGTTTTGGTCACTA,
reverse primer: 59-CCTGGCTTCTGAGAGCTACAA, and Univer-
sal ProbeLibrary probe #63, which gives a 93-nt amplicon); Mdm2
(forward primer: 59-TGGAGTCCCGAGTTTCTCTG, reverse
primer: 59-AGCCACTAAATTTCTGTAGATCATTG, and Univer-
sal ProbeLibrary probe #99, which gives a 70-nt amplicon);
kinase inhibitor 1 (p21) (forward primer: 59-TCCACAGCGATA
TCCAGACA, reverse primer: 59-GGACATCACCAGGATTGGAC,
and Universal ProbeLibrary probe #21, which leads to a 60-nt
amplicon); tumor antigen p53 (forward primer: 59-ACGCTT
CTCCGAAGACTGG, reverse primer: 59-AGGGAGCTCGAGG
CTGATA, and Universal ProbeLibrary probe #25, which leads to
a 67-nt amplicon); and Bcl2-associated X protein (BAX) (forward
primer: 59-CGGCGAATTGGAGATGAA, reverse primer: 59-GTG
TCCACGTCAGCAATCAT, and Universal ProbeLibrary probe
#56, which leads to a 65-nt amplicon). Each sample was amplified
with 1 cycle at 95°C for 10 min (to activate the polymerase) and
40 cycles at (95°C for 15 sec and 60°C for 1 min).
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